Blood Cancer Awareness Month

September is Blood Cancer Awareness Month, a time to recognize the millions of people worldwide affected by leukemia, lymphoma, and myeloma. At Nihon Kohden, we believe that advancing diagnostics is one of the most powerful ways to support the fight against these conditions. Our innovative IVD solutions enable early detection, precise monitoring, and streamlined laboratory operations, helping clinicians provide the best possible care.

Innovative Hematology Analyzers for Early and Reliable Results

Blood cancers often require prompt detection to guide urgent clinical decisions. Our hematology analyzers—Celltac G MEK-9100 and Celltac G+ MEK-9200—are developed with cutting-edge technologies to deliver:

• Comprehensive parameters (up to 39, including Immature Reticulocyte Fraction and Reticulocyte ratios)
• Micro-sampling for pediatric or critical care patients, requiring only 25–40 µL of blood
• High precision and accuracy, powered by DynaHelix Flow and advanced scatter technologies

These features empower laboratories to identify hematologic malignancies early and support clinicians in delivering timely interventions.

Efficiency for High-Volume Testing Environments

With their compact design, high throughput, and user-friendly interfaces, Nihon Kohden analyzers optimize both accuracy and efficiency. Barcode-controlled reagent management, integrated validation stations, and continuous loading systems reduce manual steps, minimize errors, and accelerate reporting—making a tangible impact in patient care.

A Shared Mission

Blood Cancer Awareness Month is not only about raising awareness but also about reinforcing the importance of collaboration between patients, clinicians, and innovators. At Nihon Kohden, we are proud to contribute through advanced diagnostic solutions that improve workflows and support life-saving decisions. Together, we move closer toward a future where blood cancers are detected earlier and treated more effectively.